ECEGEN Genetic Services
NIPT (Non-Invasive Prenatal Screening)
Comprehensive prenatal screening for common chromosomal abnormalities from a single tube of maternal blood, starting from the 10th week of pregnancy.
NIPT (Non-Invasive Prenatal Testing) is a highly accurate, simple, and safe screening test using a maternal blood sample starting from week 10. Because it only requires maternal blood, there is zero risk of miscarriage.
Cell-free DNA fragments from both mother and fetus circulate in maternal blood during pregnancy. NIPT isolates fetal DNA to detect Trisomy 21 (Down Syndrome), Trisomy 18 (Edwards Syndrome), Trisomy 13 (Patau Syndrome), Turner Syndrome (45,X), and sex chromosome abnormalities with >99.5% accuracy.
Why Choose NIPT?
- Delivers results with high accuracy exceeding 99%.
- Reports can be generated even at a low fetal fraction of 2%, eliminating the need for test repetition.
- Offers comprehensive screening of all 23 chromosome pairs and common microdeletion syndromes using advanced sequencing.
- Fast, reliable, and comprehensive testing provided under the highest standards of privacy and quality.
Who Can Have NIPT?
NIPT is recommended for all pregnant women. Because it poses zero risk to the fetus and offers high reliability, it is widely utilized worldwide.
When is NIPT Performed?
- Starting from the 10th week of pregnancy
- Wait until week 12 for twin pregnancies
- It can be performed in IVF pregnancies, pregnancies using donor eggs, and surrogate pregnancies.
How Is the NIPT Sample Collected?
Special blood collection tubes known as Streck tubes are provided at hospitals or physician clinics. These tubes contain a formaldehyde-free preservative that stabilizes nucleated blood cells, and 10 ml of blood is drawn from the expectant mother into them. Sample collection, storage, and transport must be carried out in accordance with the relevant protocol guidelines.
You can call us at (0212) 291 10 26 to learn the price of the NIPT test and for detailed information.
The NIPT test is performed at the ECEGEN Genetic Disorders Evaluation Center. Please see our contact page for directions.
The test is performed by drawing 10 ml of blood from the expectant mother into specially manufactured tubes. The collected blood must be delivered to our center at room temperature within 72 hours.
A blood sample for NIPT can be collected starting from the 10th week of pregnancy. In twin pregnancies, it is recommended to wait until the 12th week.
The report should always be evaluated together with clinical findings. A high-risk result does not constitute a definitive diagnosis; confirmation should be planned via fetal chromosome analysis following Chorionic Villus Sampling (CVS), amniocentesis, or cordocentesis, as appropriate for the gestational week.
Would you like to get information about this service or request a test?